Search research articles
Contact Us
Filters
Showing results (151-160 of 192) with videos related to
Page
of 20
Sort By:
Journal of Medical Virology
|
August 11, 2020
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study
Andrea Giacomelli, Gabriele Pagani, Anna L Ridolfo, et al.
BMJ Open
|
February 10, 2024
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors
Tommaso Clemente, Laura Galli, Riccardo Lolatto, et al.
Nature Communications
|
May 26, 2011
A novel methodology for large-scale phylogeny partition
Mattia C F Prosperi, Massimo Ciccozzi, Iuri Fanti, et al.
JMIR Public Health and Surveillance
|
July 11, 2020
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey
Fulvio Adorni, Federica Prinelli, Fabrizio Bianchi, et al.
International Journal of Antimicrobial Agents
|
November 17, 2025
Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimens
Francesca Lombardi, Elio Gentilini Cacciola, Federica Carli, et al.
Journal of the International AIDS Society
|
November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
Massimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
Plos One
|
June 21, 2017
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project
Nicola Squillace, Elena Ricci, Tiziana Quirino, et al.
The Journal of Antimicrobial Chemotherapy
|
October 13, 2019
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study
Sara Modica, David Redi, Roberta Gagliardini, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2017
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quiros Roldan, et al.
BMJ Open
|
December 5, 2019
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 192) with videos related to
Sort By:
Page
of 20
Journal of Medical Virology
|
August 11, 2020
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study
Andrea Giacomelli, Gabriele Pagani, Anna L Ridolfo, et al.
BMJ Open
|
February 10, 2024
Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors
Tommaso Clemente, Laura Galli, Riccardo Lolatto, et al.
Nature Communications
|
May 26, 2011
A novel methodology for large-scale phylogeny partition
Mattia C F Prosperi, Massimo Ciccozzi, Iuri Fanti, et al.
JMIR Public Health and Surveillance
|
July 11, 2020
Self-Reported Symptoms of SARS-CoV-2 Infection in a Nonhospitalized Population in Italy: Cross-Sectional Study of the EPICOVID19 Web-Based Survey
Fulvio Adorni, Federica Prinelli, Fabrizio Bianchi, et al.
International Journal of Antimicrobial Agents
|
November 17, 2025
Impact of DNA-stored mutations on virological response in virologically suppressed PWH in the switch to modern regimens
Francesca Lombardi, Elio Gentilini Cacciola, Federica Carli, et al.
Journal of the International AIDS Society
|
November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
Massimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
Plos One
|
June 21, 2017
Safety and tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project
Nicola Squillace, Elena Ricci, Tiziana Quirino, et al.
The Journal of Antimicrobial Chemotherapy
|
October 13, 2019
Impact of NRTI resistance mutations on virological effectiveness of antiretroviral regimens containing elvitegravir: a multi-cohort study
Sara Modica, David Redi, Roberta Gagliardini, et al.
The Journal of Antimicrobial Chemotherapy
|
January 18, 2017
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)
Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quiros Roldan, et al.
BMJ Open
|
December 5, 2019
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
Arturo Ciccullo, Gianmaria Baldin, Amedeo Capetti, et al.
Page
of 20